Improvement of autoimmune hepatitis during pregnancy followed by flare-up after delivery

American Journal of Gastroenterology

Volumn 97, Issue 12, 2002, Pages 3160-3165

  Buchel, Elwin ^a   Van Steenbergen, Werner ^a   Nevens, Frederik ^a   Fevery, Johan ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE HEPATITIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DELIVERY; DISEASE EXACERBATION; DRUG SAFETY; FEMALE; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; PREGNANCY; PRIORITY JOURNAL; SCHOOL CHILD; SCLEROSING CHOLANGITIS; SECOND TRIMESTER PREGNANCY; STILLBIRTH; TH1 CELL; TH2 CELL;

ADOLESCENT; ADULT; CHOLANGITIS, SCLEROSING; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEPATITIS, AUTOIMMUNE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 0036894958     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(02)05541-7     Document Type: Article

References (34)

1. Sherlock S, Dooley J. Diseases of the Liver and Biliary System. Oxford, UK, Blackwell Science 1997:303-9.
2. Manns MP. Autoimmune hepatitis. In: Bircher J, Benhamou JP, McIntyre N, Rizetto M, Rodés J, eds. Oxford Textbook of Clinical Hepatology. Oxford, UK, Oxford University Press, 1999:1109-20.
3. Alvarez F, Berg PA, Bianchi FB, et al. International autoimmune hepatitis group report: Update on criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999;31:929-38.
4. Manns MP, Krüger M. Immunogenetics of chronic liver disease. Gastroenterology 1994;106:1676-97.
5. Strettel MDJ, Donaldson PT, Thomson LJ, et al. Allelic basis for HLA-encoded susceptibility to type 1 autoimmune hepatitis. Gastroenterology 1997;112:2028-35.
6. Cundy TF, Butler J, Pope RM, et al. Amenorrhoea in women with non-alcoholic chronic liver disease. Gut 1991;32:202-6.
7. Donaldson PT, Farrant JM, Wilkinson ML, et al. Dual association of HLA DR2 and DR 3 with primary sclerosing cholangitis. Hepatology 1991;13:129-33.
8. Steven MM, Buckley JD, Mackay IR. Pregnancy in active hepatitis. Q J Med 1979;48:519-31.
9. Cheng Y-S. Pregnancy in liver cirrhosis and/or portal hypertension. Am J Obstet Gynecol 1977;128:812-22.
10. Schreyer P, Caspi E, El-Hindi JM, Eshchar J. Cirrhosis, pregnancy and delivery: A review. Obstet Gynecol Surv 1982;37: 304-12.
11. Burroughs AK. Liver disease and pregnancy. In: Bircher J, Benhamou JP, McIntyre N, Rizetto M, Rodés J, eds. Oxford Textbook of Clinical Hepatology. Oxford, UK, Oxford University Press, 1999;1901-13.
12. Fevery J, Nevens F. Treatment of acute esophageal variceal bleeding: A review. Eur J Intern Med 1999;10:140-5.
13. Czaja AJ, Carpenter HA, Manns MP. Antibodies to soluble liver antigen, P450IID6, and mitochondrial complexes in chronic hepatitis. Gastroenterology 1993;105:1522-8.
14. Mieli-Vergani G. Autoimmune sclerosing cholangitis: A distinct clinical entity? J Hepatol 2000;32(suppl 2):7-8.
15. Gregorio GV, Portmann B, Karani J, et al. Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: A 16 year prospective study. Hepatology 2001;33:544-53.
16. Colle I, Hautekeete M. Remission of autoimmune hepatitis during pregnancy: A report of two cases. Liver 1999;19:55-7.
17. Laifer SA, Abu-Elmagd K, Fung JJ. Hepatic transplantation during pregnancy and the puerperium. J Matern Fetal Med 1997;6:40-4.
18. Heneghan MA, Norris SM, O'Grady JG, et al. Autoimmune hepatitis: Optimal management in pregnancy and review of maternal and fetal outcomes. Hepatology 1998;28:393A (abstract 921).
19. Tennenbaum R, Marteau P, Elefant E, et al. Pregnancy outcome in inflammatory bowel disease. Gastroenterol Clin Biol 1999;23:464-9.
20. Ostensen M. Sex hormones and pregnancy in rheumatoid arthritis and systemic lupus erythematosus. Ann NY Acad Sci 1999;876:131-43.
21. Wegmann TG, Lin H, Guilbert L, Mosmann TR. Bidirectional cytokine interactions in the maternal-fetal relationship: Is successful pregnancy a TH 2 phenomenon? Immunol Today 1993; 14:353-6.
22. Whitacre CC, Reingold SC, O'Looney PA, Task Force on Gender, Multiple Sclerosis and Autoimmunity. A gender gap in autoimmunity. Science 1999;283:1277-8.
23. Wilder RL. Hormones, pregnancy and autoimmune diseases. Ann NY Acad Sci 1998;840:45-50.
24. Gervais A, Bacq Y, Bernuau J, et al. Decrease in serum ALT and increase in serum HCV RNA during pregnany in women with chronic hepatitis C. J Hepatol 2000;32:293-9.
25. Conte D, Fraquelli M, Prati D, et al. Prevalence and clinical course of chronic hepatitis C (HCV) virus infection and rate of HCV vertical transmission in a cohort of 15,250 pregnant women. Hepatology 2000;31:751-5.
26. Kirk AP, Jain S, Pocock S, et al. Late results of the Royal Free Hospital prospective controlled trial of prednisolone therapy in hepatitis B surface negative chronic active hepatitis. Gut 1980; 21:78-83.
27. Czaja AJ. Autoimmune hepatitis. Evolving concepts and treatment strategies. Dig Dis Sci 1995;40:435-56.
28. Krawitt EL. Autoimmune hepatitis. N Engl J Med 1996;334: 897-903.
29. Korelitz BI. Inflammatory bowel disease and pregnancy. Gastroenterol Clin North Am 1998;27:213-24.
30. Friedman JM, Polifka JE. The Effects of Drugs on the Fetus and Nursing Infant: A Handbook for Health Care Professionals. Baltimore: Johns Hopkins University Press, 1996.
31. Rayburn WF. Connective tissue disorders and pregnancy. Recommendations for prescribing. J Reprod Med 1998;43: 341-9.
32. Coulam CB, Moyer TP, Jiang NS, Zincke H. Breast-feeding after renal transplantation. Transplant Proc 1982;14:605-9.
33. Nyberg G, Haljamae U, Frisenette-Finch C, et al. Breastfeeding during treatment with cyclosporine. Transplantation 1998;65:253-5.
34. Begg EJ, Atkinson HC, Darlow BA. Guide to safety of drugs in breast feeding. In: Speight TM, Holford NHG, eds. Avery's Drug Treatment, 4th Ed. Auckland, New Zealand: Adis International, 1997:1701-23.